Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer

MLA

Takaaki Kobayashi, et al. “Analysis of Efficacy and Prognostic Factors for Second-Line Chemotherapy in Gemcitabine-Refractory Advanced Biliary Tract Cancer.” Annals of Oncology, vol. 27, Oct. 2016, p. vi237. EBSCOhost, https://doi.org/10.1093/annonc/mdw371.94.

APA

Takaaki Kobayashi, K. Kawai, Fumio Nagashima, J. Furuse, Daisuke Naruge, & Naohiro Okano. (2016). Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer. Annals of Oncology, 27, vi237. https://doi.org/10.1093/annonc/mdw371.94

Chicago

Takaaki Kobayashi, K. Kawai, Fumio Nagashima, J. Furuse, Daisuke Naruge, and Naohiro Okano. 2016. “Analysis of Efficacy and Prognostic Factors for Second-Line Chemotherapy in Gemcitabine-Refractory Advanced Biliary Tract Cancer.” Annals of Oncology 27 (October): vi237. doi:10.1093/annonc/mdw371.94.